Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Congenital cytomegalovirus (cCMV) infection occurs in 0.2–2% of all births in developed countries and causes developmental abnormalities.1 In addition to patients symptomatic at birth, asymptomatic newborns can develop late-onset sequelae, including sensorineural hearing loss and developmental delay. As the early identification of congenitally infected newborns may allow early intervention and antiviral treatment options, it is important to establish newborn cCMV screening programmes.
Since newborn screening assays using dried blood spots for cCMV infection were …
Funding This work was supported by Grants for the Research on Child Development and Diseases (H23-Jisedai-Ippan-001) from the Ministry of Health, Labor and Welfare, Japan.
Competing interests None.
Patient consent Obtained.
Ethics approval Asahikawa Medical University.
Provenance and peer review Not commissioned; externally peer reviewed.